Halina Bartosik-Psujek

TL;DR: A significant rise in the levels of CXCL8 and CCL5 was observed during relapse, as against the level of CCL2 which was lower when compared with the control and other MS groups, and no significant differences were observed between the stable relapsing–remitting MS and progressive MS.

TL;DR: IL-6 participation in the basic MS immune processes is confirmed by its elevated concentration in serum and CSF, its relation to disease severity with the more expressed rise in cerebrospinal fluid and some degree of dependence between serum IL-6 concentration and the level of disability in Kurtzke's scale.

TL;DR: Tau protein and 14-3-3, two intracellular proteins expressed in neurons and glial cells, were measured by enzymelinked immunoassay and were correlated with the following immune parameters in the CSF: leukocyte cell count, total protein, albumin CSF/serum ratio as a marker of disruption of the blood-brain barrier, immunoglobulin (IgG concentrations and IgG index as an indicator for intrathecal synthesis of IgG in CSF) as mentioned in this paper.

TL;DR: In this article, the authors evaluated the usefulness of serum Tau protein as possible prognostic markers for ischemic stroke and found that Tau protein concentrations measured within the early phase of IS did not correlate with degrees of neurological deficit and disability in early phase and also after 3 months of IS.